Articles
Hypertension
h 
Plasma metanephrines in the diagnosis of pheochromocytoma
(Jul 95 AIM)
h
Divergent effects of dihydropyridines and phenylalkalamine calcium channel
antagonist classes on autonomic function in human hypertension
(Jul 95 Hyp)
h
Calcium supplementation attenuates enhanced platelet function
in salt-loaded mildly hypertensive patients
(Jul 95 Hyp)
h
Differing mechanisms of action of angiotensin-converting enzyme
inhibition in black and white hypertensive patients
(Jul 95 Hyp)
h 
Efficacy and safety of losartan
(Aug 95 CJC)
h
The risk of myocardial infarction associated with antihypertensive
drug therapy
(Aug 95 JAMA)
h
Left ventricular hypercontractility in hypertensive patients with
anginal pain and normal coronary angiograms
(Aug 95 ZFK)
h 
Alterations of calcium metabolism and of parathyroid function in
primary aldosteronism and their reversal by spironolactone or by
surgical removal of aldosterone-producing adenomas
(Sep 95 AJH)
h
Use of antihypertensive drugs and trends in blood pressure in the
elderly
(Sep 95 ArIM)
h
Birth weight and blood pressure: Cross-sectional and longitudinal
relations in childhood
(Sep 95 BMJ)
h
Nifedipine: dose-related increase in mortality in patients with
coronary heart disease
(Sep 95 Circ)
h
Is white coat hypertension associated with arterial disease or left
ventricular hypertrophy?
(Sep 95 Hyp)
h
Isolated diastolic hypertension: A favorable finding among young and
middle-aged hypertensive patients
(Sep 95 Hyp)
h
White coat effect in treated hypertensive patients: Sex
differences
(Sep 95 JHH)
h
Dexamethasone-sensitive hyperaldosteronism with adrenal adenoma
- Clinical, biological, and genetic analysis
(Sep 95 PM)
Dialysis, Chronic Renal Failure
d
Reduction in recombinant human erythropoietin doses by the use of
chronic intravenous iron supplementation
(Jul 95 AJKD)
d
Beneficial effect of low-dose transdermal estrogen on bleeding
time and clinical bleeding in uremia
(Jul 95 AJKD)
d
Total body nitrogen as a prognostic marker in maintenance dialysis
patients
(Jul 95 JASN)
d
Monoclonality of parathyroid tumors in chronic renal failure and in
primary parathyroid hyperplasia
(Jul 95 JCI)
d
Renovascular disease in older patients beginning renal replacement
therapy
(Jul 95 KI)
d
Theory and validation of access flow measurement by dilution technique
during hemodialysis
(Jul 95 KI)
d
Lipid-lowering therapy in patients with renal disease
(Jul 95 KI)
d
Effect of dialysate temperature on central hemodynamics and
urea kinetics
(Jul 95 KI)
d
Late outcome of a controlled trial of enalapril treatment in
progressive renal failure. Hard end-points and influence of
proteinuria.
(Jul 95 NDT)
d
Diagnosis of iron deficiency anemia in renal failure patients in the
post-erythropoietin era
(Aug 95 AJKD)
d
Anticardiolipin antibody in patients on maintenance hemodialysis and
its association with recurrent arteriovenous graft thrombosis
(Aug 95 AJKD)
d
A comparison of mortality between patients treated with
hemodialysis and peritoneal dialysis and a comparison of causes of
death (two back-to-back papers)
(Aug 95 JASN)
d
Epidemic aluminum intoxication in hemodialysis patients traced to use
of an aluminum pump
(Aug 95 KI)
d
Mechanisms of hypoalbuminemia in hemodialysis patients
(Aug 95 KI)
d
Cross-sectional comparison of malnutrition in continuous ambulatory
peritoneal dialysis and hemodialysis patients
(Sep 95 AJKD)
d
Enalapril treatment of post-transplant erythrocytosis: Efficacy
independent of circulating erythropoietin levels
(Sep 95 AJKD)
d
Hypertension in the hemodialysis population: A survey of 649
patients
(Sep 95 AJKD)
d
Rinsing time and disinfectant release of reused dialyzers:
Comparison of formaldehyde, hypochlorite, warexin, and renalin
(Sep 95 AJKD)
d
Vancomycin removal by high-flux polysulfone hemodialysis membranes in
critically ill patients with end-stage renal disease
(Sep 95 AJKD)
d
Dialysis arthropathy: Outcome after renal transplantation
(Sep 95 AJM)
d
Bezafibrate in the management of vascular access and dialyzer
thrombosis
(Sep 95 DT)
d
Evidence that reduced lipoprotein lipase activity is not a primary
pathogenetic factor for hypertriglyceridemia in renal failure
(Sep 95 KI)
d
Accuracy of urea removal estimated by kinetic models
(Sep 95 KI)
d
Antiphospholipids in hemodialysis patients: Relationship between
lupus anticoagulant and thrombosis
(Sep 95 KI)
d
Erythropoietin enhances vascular responsiveness to
norepinephrine in renal failure
(Sep 95 KI)
d
Long-term effects of reduced renal mass in humans
(Sep 95 KI)
d
High resolution B-mode ultrasonography in evaluation of
atherosclerosis in uremia
(Sep 95 KI)
d
Calcium-regulated parathyroid hormone secretion in adynamic renal
osteodystrophy
(Sep 95 KI)
d
"Strict" blood pressure control and progression of renal
disease in hypertensive nephrosclerosis
(Sep 95 KI)
d
Effects of selenium supplementation on immune parameters in
chronic renal failure patients on haemodialysis
(Sep 95 NDT)
d
Atherogenic lipid profile in lipoprotein(a) in relation to
serum albumin in haemodialysis patients
(Sep 95 NDT)
Clinical Nephrology
c
Plasma clearance of nonradioactive iohexol as a measure of
glomerular filtration rate
(Aug 95 JASN)
c
Renal papillary necrosis: a sixteen-year clinical experience
(Aug 95 JASN)
c
Hypocalcemia after acute phosphate load is secondary to reduced
calcium efflux from bone: Studies in patients with minimal renal function and
varying parathyroid activity.
(Aug 95 JASN)
c
Relationship between appearance of urinary red blood cell/white blood cell
casts and the onset of renal relapse in systemic lupus
erythematosus
(Sep 95 AJKD)
c
ANCA and anti-GBM antibodies: two coexisting distinct
autoreactivities detectable in patients with rapidly progressive
glomerulonephritis
(Sep 95 AJKD)
c
Evaluation of dopexamine hydrochloride as a renoprotective agent
during aortic surgery
(Sep 95 AVS)
c
Hepatitis C virus associated membranous glomerulonephritis
(Sep 95 CN)
c
Hantavirus nephropathy
(Sep 95 KI)
c
The PiZ gene of alpha-1 antitrypsin as a determinant of outcome in
PR3-ANCA-positive vasculitis
(Sep 95 KI)
c
Chronic hypokalemia of adults: Gitelman's syndrome is frequent
but classical Bartter's syndrome is rare
(Sep 95 NDT)
c
Potential nephrotoxicity of intravenous infusions of naftidrofuryl
oxalate
(Sep 95 NDT)
Use back arrow on your browser to go back to HDCN home page (faster)
or click on the arrow.